Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−75.49 MUSD
12.69 MUSD
124.87 M
About Pear Therapeutics, Inc.
Sector
Industry
CEO
Christopher D. T. Guiffre
Website
Headquarters
Boston
Employees (FY)
200
Founded
2020
FIGI
BBG00YZ2R8S5
Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. The company’s lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Its second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somryst for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway while simultaneously reviewed through the FDA's Software Precertification Pilot Program. The company was founded on December 1, 2020 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PEARQ is 0.000001 USD — it hasn't changed in the past 24 hours. Watch Pear Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pear Therapeutics, Inc. stocks are traded under the ticker PEARQ.
PEARQ stock hasn't changed in a week, the last month showed zero change in price, over the last year Pear Therapeutics, Inc. has showed a 99.99% decrease.
PEARQ reached its all-time high on Dec 9, 2021 with the price of 14.600000 USD, and its all-time low was 0.000001 USD and was reached on Dec 15, 2023. View more price dynamics on PEARQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PEARQ stock is 0% volatile and has beta coefficient of 48.59. Track Pear Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pear Therapeutics, Inc. there?
Yes, you can track Pear Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Pear Therapeutics, Inc. is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
No, PEARQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2024, the company has 200.00 employees. See our rating of the largest employees — is Pear Therapeutics, Inc. on this list?
Like other stocks, PEARQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pear Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pear Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pear Therapeutics, Inc. stock shows the sell signal. See more of Pear Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.